AFMD - Affimed N V Stock Trading

Heidelberg, Germany, February 19, 2020 –  Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that its Chief Executive Officer, Dr. Adi Hoess, will present at the SVB Leeri...

Heidelberg, Germany, February 3, 2020 – Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients back their innate ability to fight cancer, today announced that Dr. Florian Fischer, Chief Financial Officer (CFO) of Affimed, passed away ...

Affimed N.V. (AFMD) has been on my watch list for a few years, but I always found a way to get distracted from clicking the buy button. In fact, I listened to the company's Q2 2018 earnings call and left ready to click the buy button in the coming weeks. Unfortunately, for me, the company subs...